For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260227:nRSa7565Ua&default-theme=true
RNS Number : 7565U Aminex PLC 27 February 2026
27 February 2026
Aminex plc
("Aminex" or "the Company")
Exercise of Options and Total Voting Rights
Aminex announces that it has issued a total of 1,500,000 ordinary shares of
€0.001 each following the exercise of options by a former employee under the
Aminex PLC Share Option Scheme (the "Option Shares"). The exercise will
provide £21,000 of additional funding to the Company, which will be used for
general working capital purposes.
Applications will be made to the Financial Conduct Authority ("FCA") and
the London Stock Exchange for the Option Shares to be admitted to the FCA's
Official List (Equity Shares (transition)) and to trading on the main market
of the London Stock Exchange ("Admission"). It is expected that Admission
will become effective and that dealings will commence in the Option Shares
at 8.00 a.m. (London time) on 6 March 2026. Following Admission, the
enlarged share capital and the total voting rights of the Company will be
4,470,001,044. The Company does not hold any shares in treasury.
The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure and Transparency Rules.
For further information:
Aminex PLC +44 203 355 9909
Charles Santos, Executive Chairman
Knights Media & Public Relations +44 203 653 0200
Jason Knights, Anthea Pitt
Davy +353 1 679 6363
Brian Garrahy
Shard Capital +44 20 7186 9952
Damon Heath
Axis Capital Markets +44 203 026 0320
Richard Hutchison
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IOESEUFEWEMSESE
Copyright 2019 Regulatory News Service, all rights reserved